While studying specificity of mouse antibodies against highly purified diphtheria toxin or toxoid, we injected Ehrlich-Lettr6 ascites tumor cells into mice in order to induce ascitic fluid for harvesting large amounts of antibody. We observed regression of Ehrlich-Lettr6 ascites tumors (ELa) only in mice injected with toxin. Subsequently we found that this effect was caused by toxin and not by toxoid, even when all animals had been preimmunized with toxoid (Fig. 1) . This observation suggested that while normal mouse tissues are relatively insensitive to diphtheria toxin (1, 2), ELa cells are sensitive to diphtheria toxin. Here we provide in vitro data confirming this hypothesis. We find that protein synthesis in ELa cells is at least 10,000 times more sensitive to diphtheria toxin than protein synthesis in normal mouse cells. Furthermore, we show by the criterion of inhibition of protein synthesis that other mouse tumor cells are sensitive to diphtheria toxin and that cells from different tumors show different degrees of sensitivity relative to normal cells.
While studying specificity of mouse antibodies against highly purified diphtheria toxin or toxoid, we injected Ehrlich-Lettr6 ascites tumor cells into mice in order to induce ascitic fluid for harvesting large amounts of antibody. We observed regression of Ehrlich-Lettr6 ascites tumors (ELa) only in mice injected with toxin. Subsequently we found that this effect was caused by toxin and not by toxoid, even when all animals had been preimmunized with toxoid ( Fig. 1 ). This observation suggested that while normal mouse tissues are relatively insensitive to diphtheria toxin (1, 2) , ELa cells are sensitive to diphtheria toxin. Here we provide in vitro data confirming this hypothesis. We find that protein synthesis in ELa cells is at least 10,000 times more sensitive to diphtheria toxin than protein synthesis in normal mouse cells. Furthermore, we show by the criterion of inhibition of protein synthesis that other mouse tumor cells are sensitive to diphtheria toxin and that cells from different tumors show different degrees of sensitivity relative to normal cells.
We also present preliminary data indicating that protein synthesis in human breast carcinoma cells and human melanoma cells is more sensitive to diphtheria toxin than protein synthesis in cells from normal human breast or skin. 
We next tested the sensitivity of protein synthesis in several human tumors to diphtheria toxin (Figs. 3 and 4) . Cells from metastatic breast carcinomas of two separate patients were sensitive compared to normal breast cells or to skin cells from one of the two patients. Protein synthesis in cells from breast carcinoma no. 2 was inhibited 50% by 0.03 pg of diphtheria toxin, the same sensitivity displayed by HeLa cells at that dose. The cells from breast carcinoma no. 1 required 3.0 pg of diphtheria toxin for protein synthesis to be inhibited 50%. Nevertheless, this tumor also appears sensitive to diphtheria toxin when compared to cells from normal breast or skin. Microscopic examination of the malignant tissue samples indicated that they contained both malignant cells and some normal cells. In view of the contamination of malignant samples with normal cells, we tested the sensitivity of cells from adjacent tissue underlying carcinoma no. 1. Microscopic examination of this tissue showed it to contain many normal cells and fewer malignant cells. Cells from this sample showed intermediate sensitivity, suggesting that this method might be used to discriminate between normal and malignant cells. In these and in other tumor tissues examined it has been our experience that the steepness of the sensitivity curve is a reflection of the relative proportions of normal and malignant cells. have tested samples of normal human heart and pancreas, which are the most sensitive organs in the guinea pig (10) . Human heart and pancreas cells behaved like skin cells in their diphtheria toxin sensitivity (data not shown).
DISCUSSION
Diphtheria toxin is a potent inhibitor of protein synthesis in mammalian cells. The toxin may be cleaved by some proteolytic enzymes into two polypeptide fragments, A and B (11, 12) . The B portion of the molecule facilitates binding of diphtheria toxin to the cell membrane (13) . Fragment A is an enzyme that inhibits protein synthesis by catalyzing the transfer of adenosine diphosphate ribose from NAD to elongation factor 2, thereby preventing continued growth of polypeptide chains (1, 14) . Tissues or cultured cells of all animal species are not equally susceptible to diphtheria toxin (2). Since elongation factor 2 extracted from resistant cells is also sensitive to the enzyme activity of fragment A (1, 15), it is believed that resistance to diphtheria toxin is a property of the cell membrane. Resistance may reflect the absence or masking of cell receptors for the toxin or the failure of bound toxin to enter the cell (16).
Although not yet proven, the differential sensitivity of protein synthesis in tumor cells may also be a property of the cell membrane. Normal mice or cell lines derived from normal mouse tissues are highly resistant to diphtheria toxin (2, 17) . Our results with mouse spleen and thymus cells (Fig. 2) conclusions. The regression of ELa tumors in mice injected with diphtheria toxin (based on the weight of animals and visual observations) (Fig. 1) , suggested that malignant transformation increases the sensitivity of mouse cells to diphtheria toxin. Protein synthesis in ELa tumor cells tested in vitro was at least 10,000 times more sensitive to diphtheria toxin than that of cells from normal mouse tissues (Fig. 2) . During the preparation of this manuscript, Buzzi and Maistrello (18) reported that the development of Ehrlich tumors was indeed inhibited if mice were injected with crude diphtheria toxin at intervals after tumor inoculation. Although they carried out no experiments in vitro, they suggested that Ehrlich cells might be more sensitive to diphtheria toxin. Our observations confirm that diphtheria toxin will prevent in vivo development of ELa tumors, and our experiments in vitro show clearly that ELa cells and other mouse tumor cells are more -sensitive to diphtheria toxin.
The in vitro experiments reported here leave no doubt that by the criterion of inhibition of protein synthesis some tumor cells are more sensitive to diphtheria toxin than some normal cells from the same species. Thus, in mice (Fig. 2) , ELa (carcinoma) cells were the most sensitive to diphtheria toxin, lymphoma and myeloma cells displayed intermediate sensitivity, and normal spleen and thymus cells were relatively insensitive. Relative sensitivities among tumors, seen also in the human samples (Figs. 3 and 4) , cannot at this time be ascribed to individual differences between the tumors themselves. As indicated above, our experience thus far suggests that the slopes of the sensitivity curves reflect the degree to which tumor cells are contaminated with normal cells, but this observation remains to be demonstrated quantitatively.
The lymphoma we used (6C3HED) has thymus-derived (T cell) characteristics (C. Bianco (19) . We suggest that diphtheria toxin might be used for anticancer therapy in patients whose tumors are shown to be sensitive in vitro if our preliminary observations can be extended to other animal species and broadened to include additional human samples. While sublethal doses of toxin may themselves prove therapeutic, higher doses might be possible. In the latter case, individuals might be protected from generalized toxicity either by preimmunization or by concurrent administration of passive antitoxin antibody.
